Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrizia Apollonio"'
Autor:
Giovanni Scambia, Gian Franco Zannoni, Gianluigi Passetti, Enrica Martinelli, Ezio Bombardelli, Cristiano Ferlini, Antonella Riva, Paolo Morazzoni, Daniela Gallo, Patrizia Apollonio
Publikováno v:
Menopause. 12:589-600
This study was aimed to assess the effect of a standardized soy extract (SSE, Soyselect) in the ovariectomized rat model of menopause.Ovariectomized rats were treated for 6 weeks with the soy extract (50 or 100 mg/kg/day - PO), vehicle (distilled wat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4f3d63dbfcf4306498cf18422044982
https://doi.org/10.1097/01.gme.0000156348.61767.d5
https://doi.org/10.1097/01.gme.0000156348.61767.d5
Autor:
Sabrina Giacomelli, Silvia Prislei, Giuseppina Raspaglio, Giovanni Scambia, Patrizia Apollonio, Cristiano Ferlini, Paolo Morazzoni, Ezio Bombardelli, Daniela Gallo, Antonella Riva
Publikováno v:
European Journal of Cancer. 39:2403-2410
This study aimed to assess, in an in vivo experimental model, the growth inhibitory effects of IdB 1016 (Silipide, a complex of silybin/phosphatidylcholine) when used as a single agent against human ovarian cancer. We also wanted to investigate the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f986ca94c79e40e9287ec25bb0ebde
https://doi.org/10.1016/s0959-8049(03)00624-5
https://doi.org/10.1016/s0959-8049(03)00624-5
Autor:
Giovanni Scambia, Cristiano Ferlini, Sabrina Giacomelli, Mariagrazia Distefano, Antonella Riva, Patrizia Apollonio, Ezio Bombardelli, Paolo Morazzoni, Daniela Gallo, Salvatore Mancuso
Publikováno v:
Life Sciences. 70:1447-1459
In this study we investigated whether the flavonoid silybin and its bioavailable derivative IdB 1016 (silipide) could enhance the antitumour activity of cisplatin (CDDP), the most commonly used drug in the treatment of gynaecological malignancies. Si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794e959f597572dbb052de2edd254fed
https://doi.org/10.1016/s0024-3205(01)01511-9
https://doi.org/10.1016/s0024-3205(01)01511-9
Autor:
Salvatore Mancuso, Giovanni Scambia, E. Fruscella, Cristiano Ferlini, Daniela Gallo, Patrizia Apollonio
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 16(1)
Both gemcitabine and liposomal doxorubicin are antineoplastic drugs with clinical activity in platinum-refractory ovarian cancer. The purpose of this study was to evaluate the antitumor activity of a combination gemcitabine/liposomal doxorubicin admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2503a01f8ddd9a233c56728a7f4c0bff
https://pubmed.ncbi.nlm.nih.gov/16445637
https://pubmed.ncbi.nlm.nih.gov/16445637